FDA Inspection 1250182 — OurPharma LLC

OurPharma LLC — FEI 3014064135

The FDA completed an inspection of OurPharma LLC on September 27, 2024 in Fayetteville, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fayetteville, AR (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
143321 CFR 211.42(c)(10)(iii)Air Supply
22779FDCA 503B(b)(2)(A)All inclusive product report, not submitted
22787FDCA 503B(a)(10)(A)Drug product labels, fails to include
22789FDCA 503B(a)(10)(B)Drug product container, fails to include